Women's hearts are hard to break

Lancet

Volumn 349, Issue SUPPL.1, 1997, Pages

  Newnham, Harvey H ^a   Silberberg, Jonathan ^b  

^a MONASH UNIVERSITY   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY RISK; DEVELOPING COUNTRY; ESTROGEN THERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SEX DIFFERENCE; SHORT SURVEY; SOCIAL CLASS; CORONARY ARTERY DISEASE; REVIEW; RISK FACTOR; WOMEN'S HEALTH;

CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PRIMARY PREVENTION; RISK FACTORS; WOMEN'S HEALTH;

EID: 0031047456     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90002-7     Document Type: Article

References (40)

1. National Heart Foundation of Australia. Heart facts. Woden, ACT: NHFA, 1996.
2. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A for the WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994; 90: 583-612.
3. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344: 1383-89.
4. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-09.
5. Vanwijk CMTG, Vanvliet KP, Kolk AM. Gender perspectives and quality of care - towards appropriate and adequate health care for women. Soc Sci Med 1996; 43: 707-20.
6. Healy B. The Yentl syndrome. N Engl J Med 1991; 325: 274-76.
7. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991; 337: 1387-93.
8. Powell LH, Shaker LA, Jones BA, Vaccarino LV, Thoresen CE, Pattillo JR. Psychosocial predictors of mortality in 83 women with premature acute myocardial infarction. Psychosom Med 1993; 55: 434-35.
9. Blair SN, Kohl HW III, Paffenbarger RS Jr, et al. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 1989; 262: 2395-401.
10. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995; 332: 1758-66.
11. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute risk of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303-09.
12. Jacobs DR Jr, Meban IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32-47.
13. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-47.
14. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chron Dis 1986; 39: 809-21.
15. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-46.
16. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-49.
17. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156-62.
18. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons - the established populations for epidemiologic studies of the elderly. Am J Clin Nutr 1996; 64: 190-96.
19. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994; 140: 256-61.
20. Newnham HH. Oestrogens and atherosclerotic vascular disease - lipid factors. Balliere's Clin Endocrinol Metab 1993; 7: 61-93.
21. Guetta V, Cannon O. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996; 93: 1928-37.
22. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
23. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199-208.
24. Matthews KA. Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy are users healthier than nonusers? Am J Epidemiol 1996; 143: 971-78.
25. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102-09.
26. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effects of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133-36.
27. Guetta V, Panza JA, Waclawiw MA, Cannon RO. Effect of combined 17-β oestradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. Am J Cardiol 1995; 75: 1274-76.
28. Espeland MA, Applegate W, Furberg CD, et al. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 1995; 142: 1011-19.
29. Barker DJ. The fetal origins of coronary heart disease. BMJ 1995; 311: 171-74.
30. Redman S, Hennrikus DJ, Bowman JA, Sanson-Fisher RW. Assessing women's health needs. Med J Aust 1988; 148: 123-27.
31. Pilote L, Hlatky MA. Attitudes of women toward hormone replacement therapy and prevention of heart disease. Am Heart J 1995; 129: 1237-38.
32. Silberberg JS, Magnus P. What will we tell the public? The coverage of cigarette smoking by Australian magazines. Sydney: Action on Smoking & Health, 1988.
33. PMO Philip Morris Companies Inc. Half yearly report to shareholders. 1996 midyear update, Sep 27, 1996.
34. Adams J. "Altered images", Vogue Australia Condé Naste, November, 1996, 125-65.
35. Australian Longitudinal Study on Women's Health. Faculty of Medicine, University of Newcastle, Data Books, December 1996.
36. Peto R. Tobacco - the growing epidemic in China. JAMA 1996; 275: 1683-84.
37. Vijakumar M, Narula J, Reddy KS, Kaplan EL. Incidence of rheumatic fever and prevalence of rheumatic heart disease in India. Int J Cardiol 1994; 43: 221-28.
38. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
39. Lau EMC. Admission rates for hip fracture in Australia in the last decade. Med J Aust 1993; 158: 604-06.
40. Australian Bureau of Statistics. Causes of death - Australia. ABS catalogue no 3303.0, 1994.